Ren-Ke Li, MD, PhD
Dr. Ren-Ke Li, MD, Ph.D. is a Professor of Medicine in the Department of Surgery, Division of Cardiac Surgery at the University of Toronto. Dr. Li is also a Senior Scientist at the Toronto General Research Institute, University Health Network working in the field of stem cell transplantation and tissue engineering. He is the recipient of the Canada Research Chair in Cardiac Regeneration (Tier 1) and was a Career Investigator of the Heart and Stroke Foundation of Canada. Dr. Li has been at the forefront in the field of cell transplantation and tissue engineering. Over 25 years his research group has defined muscle cell transplantation for Cardiac Repair, followed by stem cell transplantation for Cardiac Regeneration. Both cell repair and regeneration technologies have been translated to a clinical application at Phase I and II levels. Since the patients with heart failure are aged population, currently, his research group is attempting to determine the mechanisms by which transplanted cells exert their beneficial effects by Rejuvenation of aged stem cells and aged recipients. Clarifying these mechanisms of Repair, Regeneration and Rejuvenationwill allow them to develop the “next generation” of cell therapy for restoration of heart function of aged patients.
While members of the Medical Advisory Board are consulted to provide third party expert medical input into Triple-Gene’s product development efforts and clinical trial activities, they do not dictate or direct, nor are they responsible for, any development or clinical activities ultimately undertaken by Triple-Gene.